Skip to main content
. 2023 Oct 14;15(1):129–135. doi: 10.1007/s13193-023-01828-3

Table 2.

Factors affecting OS and DFS as per Cox regression

Characteristic Variable HR (OS) 95% CI (OS) p Value (OS) HR (RFS) 95% CI (RFS) p value
Age < 50
> 50 0.6 0.7 to 1.4 0.32 0.46 0.72 to 1.6 0.48
Sex Male
Female 0.55 0.27 to 1.1 0.09 0.81 0.32 to 2.0 0.66
Location Middle
Lower 1.0 0.79 to 1.5 0.57 1.3 0.81 to 2.1 0.26
Neoadjuvant chemotherapy Single
Dual 1.1 0.58 to 2.2 0.70 0.52 0.21 to 1.3 0.17
Histological differentiation WD
MD 1 0.52 to 1.9 1 0.8 0.8 to 1.4 0.43
PD 0.98 0.43 to 2.2 0.96 0.59 0.43 to 1.59 0.51
NOS 2.4 0.90 to 3.1 0.06 0 0 to infinity 0.97
Type of surgery VATS
Open 1.01 0.64 to 2.0 0.64 22.4 0 to infinity 0.95
THE 1.11 0.39 to 2.6 0.95 0 0 to infinity 0.94
Pathological complete response Yes
No 1.45 0.99 to 2.14 0.057 1.5 0.87 to 2.6 0.13
Lymph node positivity Yes
No 1.1 0.79 to 1.5 0.50 0.94 0.59 to 1.5 0.80
Type of lymphadenectomy E2F
2F 0.7 0.36 to 1.5 0.42 16 0 to Infinity 0.98
1F 1.6 0.61 to 4.2 0.32 0 0 to infinity 0

RFS recurrence-free survival, OS overall survival, HR hazard ratio, CI confidence intervalm, WD well differentiated, MD moderately differentiated, PD poorly differentiated, NOS not otherwise specified, VATS video-assisted thoracoscopic surgery, THE transhiatal esophagectomy, E2F extended two field, 2F two field, 1F single field